John Divine

John Divine

John Divine is currently an investing reporter at U.S. News & World Report, and was previously an assistant editor at InvestorPlace.com. He has worked variously in the fields of commercial real estate, money management and digital media, working as a financial journalist for most of his professional career.

John has also been a regular contributor to The Motley Fool, and his work also has appeared on AOL DailyFinance.

In 2013, he shortened his bucket list when he saw Warren Buffett live and in the flesh while covering the Berkshire Hathaway Annual Shareholders’ Meeting.

A proud North Carolinian and graduate of Appalachian State University, John majored in Finance & Banking. He enjoys basketball, reading, writing and food. He does not care for the Oxford comma, and he does not require the food he enjoys to be nutritious.

Recent Articles

Yum Brands FINALLY Announces YUM China Spinoff

YUM stock cratered 19% two weeks ago on Wednesday. The reason? YUM China was falling apart. Two weeks later, the YUM China spinoff de-risks the company.

Amazon Earnings Preview: Why Q3 Should Catapult AMZN Stock Past $600

AMZN is the second-hottest S&P stock of 2015, up 84% to-date. With Amazon earnings slated for Thursday p.m., the rally isn't over.

DO NOT Buy Chipotle Mexican Grill, Inc. (CMG) Stock Before Earnings!

Chipotle (CMG) stock could go up or down after Q3 Chipotle earnings are announced on Tuesday. But if I were a betting man, I'd say CMG falls.

Why Now Is the Time to Pile Back Into Biotech Stocks (IBB, XBI)

For years, biotech stocks have outperformed the market. In light of their recent downturn, now's a fine time to buy biotech ETFs like IBB and XBI.

Amazon.com, Inc. (AMZN) Aims to Kick India Into Hypergrowth

Amazon (AMZN) hauls in $33 billion annually from overseas. India is a core part of its international growth ambitions.